{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:37:38Z","timestamp":1762331858109,"version":"build-2065373602"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K6776"],"award-info":[{"award-number":["23K6776"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1038\/s41375-025-02782-5","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T07:10:06Z","timestamp":1759734606000},"page":"2812-2815","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combined treatment with amlexanox and cytarabine induces apoptosis via the S100A6\u2013Akt pathway in KMT2A::AFF1-positive acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9652-4559","authenticated-orcid":false,"given":"Hayato","family":"Tamai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayaka","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8275-5372","authenticated-orcid":false,"given":"Ayako","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"2782_CR1","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/S0140-6736(02)08782-2","volume":"359","author":"CH Pui","year":"2002","unstructured":"Pui CH, Gaynon PS, Boyett JM, Chessells JM, Baruchel A, Kamps W, et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet. 2002;359:1909\u201315.","journal-title":"Lancet"},{"key":"2782_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2011.37","volume":"1","author":"H Tamai","year":"2011","unstructured":"Tamai H, Miyake K, Yamaguchi H, Takatori M, Dan K, Inokuchi K, et al. Blood Cancer J. 2011;1:e38.","journal-title":"Blood Cancer J"},{"key":"2782_CR3","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1038\/s41375-020-0901-2","volume":"34","author":"THM Grahn","year":"2020","unstructured":"Grahn THM, Niroula A, V\u00e9gv\u00e1ri \u00c1, Oburoglu L, Pertesi M, Warsi S, et al. S100A6 is a critical regulator of hematopoietic stem cells. Leukemia. 2020;34:3323\u201337.","journal-title":"Leukemia"},{"key":"2782_CR4","doi-asserted-by":"publisher","first-page":"11712","DOI":"10.1073\/pnas.1634990100","volume":"100","author":"HR Luo","year":"2003","unstructured":"Luo HR, Hattori H, Hossain MA, Hester L, Huang Y, Lee-Kwon W, et al. Akt as a mediator of cell death. Proc Natl Acad Sci USA. 2003;100:11712\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2782_CR5","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/sj.leu.2401129","volume":"12","author":"R Pieters","year":"1998","unstructured":"Pieters R, den Boer ML, Durian M, Janka G, Schmiegelow K, Kaspers GJ, et al. Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia-implications for treatment of infants. Leukemia. 1998;12:1344\u20138.","journal-title":"Leukemia"},{"key":"2782_CR6","doi-asserted-by":"crossref","unstructured":"Tamai H, Yamaguchi H, Miyake K, Takatori M, Kitano K, Yamanaka S, et al. Amlexanox Downregulates S100A6 to Sensitize KMT2A\/AFF1-Positive Acute Lymphoblastic Leukemia to TNFa Treatment. Cancer Res. 2017;77; 4426\u201333.","DOI":"10.1158\/0008-5472.CAN-16-2974"},{"key":"2782_CR7","unstructured":"Miyake T, Susumu Kishimoto S, Shimizu M, Nakamura M. Phase I Clinical Trial of the Antiallergic Agent Amlexanox (AA-673). J Clin Therapeutics Med. 1986;2:23\u201325."},{"key":"2782_CR8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0145-2126(98)00045-9","volume":"22","author":"N Balasubramanian","year":"1998","unstructured":"Balasubramanian N, Advani SH, Zingde SM. Protein kinase C isoforms in normal and chronic myeloid leukemic neutrophils. Distinct signal for PKC alpha by immunodetection on PVDF membrane, decreased expression of PKC alpha and increased expression of PKC delta in leukemic neutrophils. Leuk Res. 1998;22:597\u2013604.","journal-title":"Leuk Res"},{"key":"2782_CR9","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/bmt.2014.18","volume":"49","author":"H Tamai","year":"2014","unstructured":"Tamai H, Miyake K, Yamaguchi H, Shimada T, Dan K, Inokuchi K. Inhibition of S100A6 induces GVL effects in MLL\/AF4-positive ALL in human PBMC-SCID mice. Bone Marrow Transpl. 2014;49:699\u2013703.","journal-title":"Bone Marrow Transpl"},{"key":"2782_CR10","first-page":"759","volume":"93","author":"A Dosanjh","year":"2020","unstructured":"Dosanjh A, Won CY. Amlexanox: a novel therapeutic for atopic, metabolic, and inflammatory disease. Yale J Biol Med. 2020;93:759\u201363.","journal-title":"Yale J Biol Med"},{"key":"2782_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/sj.leu.2404031","volume":"20","author":"RW Stam","year":"2006","unstructured":"Stam RW, Hubeek I, den Boer ML, Buijs-Gladdines JG, Creutzig U, Kaspers GJ, et al. MLL gene rearrangements have no direct impact on Ara-C sensitivity in infant acute lymphoblastic leukemia and childhood M4\/M5 acute myeloid leukemia. Leukemia. 2006;20:179\u201382.","journal-title":"Leukemia"},{"key":"2782_CR12","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1200\/JCO.1983.1.12.763","volume":"1","author":"RL Capizzi","year":"1983","unstructured":"Capizzi RL, Yang JL, Cheng E, Bjornsson T, Sahasrabudhe D, Tan RS, et al. Alteration of the pharmacokinetics of high-dose ara-C by its metabolite, high ara-U in patients with acute leukemia. J Clin Oncol. 1983;1:763\u201371.","journal-title":"J Clin Oncol"},{"key":"2782_CR13","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1021\/bi9019077","volume":"49","author":"SG Rani","year":"2010","unstructured":"Rani SG, Mohan SK, Yu C. Molecular level interactions of S100A13 with amlexanox: inhibitor for formation of the multiprotein complex in the nonclassical pathway of acidic fibroblast growth factor. Biochemistry. 2010;49:2585\u201392.","journal-title":"Biochemistry"},{"key":"2782_CR14","doi-asserted-by":"publisher","first-page":"e0161663","DOI":"10.1371\/journal.pone.0161663","volume":"11","author":"CC Cho","year":"2016","unstructured":"Cho CC, Chou RH, Yu C. Amlexanox blocks the interaction between S100A4 and epidermal growth factor and inhibits cell proliferation. PLoS One. 2016;11:e0161663.","journal-title":"PLoS One"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02782-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02782-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02782-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:34:35Z","timestamp":1762331675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02782-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":14,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2782"],"URL":"https:\/\/doi.org\/10.1038\/s41375-025-02782-5","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"type":"print","value":"0887-6924"},{"type":"electronic","value":"1476-5551"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"21 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}